Merck scraps disappointing experimental cholesterol drug
FILE – In this Dec. 18, 2014, file photo, a person walks through a Merck company building in Kenilworth, N.J. Merck has decided to abandon efforts to market a closely watched experimental cholesterol medicine after mediocre test results. Merck’s decision
0 Comments